0001600132-16-000083.txt : 20160621
0001600132-16-000083.hdr.sgml : 20160621
20160621181052
ACCESSION NUMBER: 0001600132-16-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160617
FILED AS OF DATE: 20160621
DATE AS OF CHANGE: 20160621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luehring Jens
CENTRAL INDEX KEY: 0001631764
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 161725220
MAIL ADDRESS:
STREET 1: C/O LINDE NORTH AMERICA INC.
STREET 2: 575 MOUNTAIN AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
wf-form4_146654703894746.xml
FORM 4
X0306
4
2016-06-17
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001631764
Luehring Jens
C/O LINDE NORTH AMERICA, INC.
200 SOMERSET CORPORATE BLV, SUITE 7000
BRIDGEWATER
NJ
08807
1
0
1
0
Stock Option (right to buy)
1.94
2016-06-17
4
A
0
10000
0
A
2026-06-16
Common Stock
10000.0
10000
D
This option was granted on June 17, 2016. This option vests in three equal annual installments over a three-year period from the date of grant.
/s/ Jens Luehring
2016-06-21